Literature DB >> 1153837

Separation and quantitative analysis of furosemide and 4-chloro-5-sulfamoylanthranilic adid (CSA) by high pressure liquid chromatography.

M L MacDougall, D W Shoeman, D L Azarnoff.   

Abstract

After extraction by ether from acidified plasma or urine and concentration into basic phosphate buffer, furosemide and 4-chloro-5-sulfamoylanthranilic acid (CSA) were separated on a high pressure liquid ion-exchange system and measured fluorometrically. Sensitivity is 0.2 mug/ml of ether compound in plasma and 0.1 mug/ml in urine with an 8% coefficient of variation. Interference by porphyrins in urine was eliminated by subtracting a second fluorometric measurement at a different wave-length from that used for furosemide. No quenching at this wave-length is seen with concentrations of furosemide up to 50 mug/ml. Standard curves of furosemide and CSA are linear from 0.2 mug/ml to 50 mug/ml.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1153837

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  4 in total

Review 1.  Clinical pharmacokinetics of frusemide.

Authors:  R E Cutler; A D Blair
Journal:  Clin Pharmacokinet       Date:  1979 Jul-Aug       Impact factor: 6.447

2.  Effect of furosemide on angiotensin II-mediated prostaglandin I2 production in hypertensive subjects.

Authors:  A Fujimura; A Ebihara
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  The effect of propranolol on urinary prostaglandin E2 after frusemide administration in healthy subjects.

Authors:  A Fujimura; H Kajiyama; A Ebihara
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

4.  Renal clearance of lomefloxacin is decreased by furosemide.

Authors:  T Sudoh; A Fujimura; T Shiga; M Sasaki; K Harada; T Tateishi; K Ohashi; A Ebihara
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.